How to Buy Coherus Biosciences Stock

Coherus Biosciences Inc

Coherus BioSciences, Inc. , a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States.

Coherus Biosciences stock last closed at $0.88, up 1.5% from the previous day, and has decreased 45.34% in one year. It has overperformed other stocks in the Biotechnology industry by 0.25 percentage points. Coherus Biosciences stock is currently +33.33% from its 52-week low of $0.66, and -63.79% from its 52-week high of $2.43.

As of Jul 11, 2025, there are 115.93M shares of CHRS outstanding. The market value of CHRS is $102.02M. In the last 24 hours, 1.69M CHRS shares were traded.

How to Buy Coherus Biosciences Stock

Not sure how to invest in Coherus Biosciences stock? Here's how.

  1. Figure out where to buy Coherus Biosciences stock: You need to decide on a stock brokerage, but don't worry - we've analyzed dozens of online stock brokerages and apps to help you figure out where to buy Coherus Biosciences stock.
  2. Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
  3. Deposit funds into your investment account: Pick your payment method and add your information.
  4. Evaluate Coherus Biosciences stock: The Coherus Biosciences ticker symbol is CHRS. Is Coherus Biosciences stock a good investment? Should you buy shares of CHRS? How do CHRS's underlying business fundamentals look? Do top analysts think Coherus Biosciences is a good buy? Why has CHRS's stock price moved recently? (Hint: Our stock market research tools can help you figure out if CHRS is a good stock to buy).
  5. Make your CHRS trade: Decide if you will purchase CHRS shares at the current market price or use a limit order to buy CHRS shares at a given price.
  6. Keep tabs on your investment in CHRS: Create a watchlist to key updates about your position in Coherus Biosciences shares.

Step 1: Figure out where to buy Coherus Biosciences stock

You will need a brokerage account to access the NASDAQ market and buy CHRS shares.

A brokerage account is an investment account that enables you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.

Our favorite brokerage: eToro

Based on our analysis, eToro is the best online stock brokerage. eToro gives you:

  • Invest in stocks with 0% commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
  • Access to global markets: From Tech to Financial Services, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
  • Social investing: eToro boasts a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other financial assets: Such as ETFs and cryptos.

Get $10 towards your purchase of shares by creating an account with eToro now. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Sign up for your brokerage account

Now that you've selected your brokerage, the next step is to fill out some personal details so you can invest in CHRS today.

How to Start a New Investment Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Provide your personal data to open your new brokerage account.
  1. Submit your data by hitting the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Deposit funds into your investment account

Now that you have opened your account on the stock trading app, you need to deposit funds:

Check out the tutorial below to see the process of depositing funds into your new investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Evaluate Coherus Biosciences stock

After you have identified the best place to buy Coherus Biosciences stock, it's absolutely critical to evaluate their stock prior to investing, so you can wrap your head around the risk and upside.

Overview of key CHRS info

CHRS Price
$0.88
1w %
17.96%
1y %
-45.34%
5y %
-95.04%
P/E
-0.78x
P/B
-0.56x
P/S
0.52x
PEG
N/A
Revenue
$197.50M
Earnings
-$130.94M
Fore. Rev. Growth
-3.97%
Fore. Earn. Growth
N/A
Market Cap
$102.02M
Next Earnings
Jul 31, 2025
Next Dividend
N/A

CHRS Fundamentals

WallStreetZen was built to help everyday investors perform more in-depth fundamental analysis in minutes instead of hours.

You can see all of the due diligence checks on CHRS's stock page.

How is CHRS stock valued?

Investors use many financial metrics, analyses, models, and charts to gauge CHRS's intrinsic value.

You can do more valuation research on CHRS's stock here.

Is CHRS a healthy company?

Pros:

  • There are more short-term assets than short-term liabilities on the CHRS balance sheet.
  • There are more short-term assets than long-term liabilities on the CHRS balance sheet.

Cons:

  • Total CHRS debt is still negative.
  • CHRS earnings of -$112.75M is not enough to cover its interest payments.
  • CHRS's operating cash flow of $500.00k allows it to safely service it's debt of $268.20M.
  • CHRS debt to equity ratio of -3.02 is negative.
  • CHRS profit margin has gone down from -26.1% to -66.3% in the past year.

Is it a good time to buy Coherus Biosciences stock, according to analysts?

Out of 2 Wall Street analysts who research CHRS, the consensus analyst rating on Coherus Biosciences is a Buy

Please keep in mind that analyst forecasts are not recommendations, nor are they investment advice.

You can dive deeper into what analysts are saying on the Coherus Biosciences stock forecast page.

CHRS Momentum

SMA10
0.8
SMA20
0.78
SMA50
0.83
SMA100
0.9
SMA200
1.04
MACD
0.01
MACD Signal
-0.01
MACD Histogram
0.02
RSI
60.34
Stochastic %K
90.21
Stochastic %D
86.03
StochRSI %K
99.78
StochRSI %D
93.2

How is CHRS performing as a company?

Last year, CHRS revenue was $197.50M. During the past five year, CHRS's revenue has increased by -14.61% per year. This was slower than the Biotechnology industry average of 43.33%.

Dive into CHRS's earnings and revenue performance here.

Are CHRS insiders buying or selling the stock?

Over the past year, insiders at CHRS have sold more shares than they have bought.

Mats Wahlstrom, Director of CHRS, was the latest CHRS insider to sell. They sold $73,891.13 worth of CHRS stock on May 23, 2025.

Dig into more about who owns CHRS stock here.

Can I rely on CHRS as an income stream?

No, Coherus Biosciences doesn't provide an income stream by paying out dividends.

What do other investors have to say about CHRS?

One of the primary reasons eToro is our favorite brokerage is because of its social trading community.

Click below to see what other community members have to say.

Step 5: Make your CHRS trade

There are two primary types of orders:

  • Market order: A market order is an order to buy or sell a security at the best price on the market.
    Market orders are usually fine.
  • Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
    If you want to make sure you're buying or selling at a specific price limit, place a limit order.

Press the Open Trade button and eToro will execute your order.

If you want more help with investing in stocks on eToro, watch the how to video below:

Open eToro Account

Step 6: Keep tabs on your investment in CHRS

Now that you own some CHRS stock, you'll want to keep up with your shares.

Make a watchlist to track your CHRS stock.

CHRS Feed

How to Buy Stock in Coherus Biosciences

To summarize, here are the 6 steps to buy stock in Coherus Biosciences:

  1. Figure out where to buy Coherus Biosciences stock
  2. Sign up for your brokerage account
  3. Deposit funds into your investment account
  4. Evaluate Coherus Biosciences stock
  5. Make your CHRS trade
  6. Keep tabs on your investment in CHRS

If you require a brokerage account, eToro is our favorite option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to get notifications regarding your new investment in Coherus Biosciences, create your watchlist below.

NASDAQ: CHRS
$0.88+0.01 (+1.5%)
Updated Jul 11, 2025
Open eToro Account
Your capital is at risk.
NASDAQ: CHRS
$0.88+0.01 (+1.5%)
Updated Jul 11, 2025
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Coherus Biosciences share?

As of Jul 11, 2025, it costs $0.88 to buy one share of Coherus Biosciences stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.44, you can buy 0.5 shares of CHRS.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Coherus Biosciences stock?

According to 2 Wall Street analysts who monitor Coherus Biosciences, their consensus recommendation is to buy Coherus Biosciences stock.

What is the best way to buy Coherus Biosciences stock?

One way to place an order for Coherus Biosciences stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.